ARCHIVES

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 28 | July 11, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

In Brief: Muggia Leaving NCI For NYU In September; Seminar Planned On radiation Exposures

April 20, 1979

For Frederick, Unseat Program Resources Inc.

March 3, 1995

Full Text Of Saffiotti’s Statement

May 7, 1976

41 CCOPs Reported For Recompetition

February 23, 1990